Your search for major depressive disorder returned 66 results

Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.

Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.

Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.

Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.

Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.

The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.

The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.

Investigators sought to assess associations for US Army soldiers bullied by fellow soldiers with mental health outcomes.

Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.

Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.

Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.

Investigators aimed to evaluate the efficacy of combined treatment (antidepressants plus STPP) vs antidepressants (with or without brief supportive psychotherapy) on depressive symptoms in adults in acute-phase depression.

Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Researchers compared grey matter volume patterns in adult patients with attention-deficit/hyperactivity disorder and bipolar disorder.

Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.

Researchers sought to investigate the associations between time perception, intensity of physical activity, impulsivity, anxiety and depressive symptoms, and the degree to which resting state motion intensity can be used to recognize anxiety and depressive symptoms.

Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.

Looking at stress and university students during the COVID-19 pandemic.

Investigators sought to find out if the psychiatric effects of the COVID-19 pandemic were more strongly pronounced in individuals with lower economic and personal capital.

A cross-sectional family study sought to determine if parents’ transmission of anxiety is sex specific.

The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.

Outpatients were recruited at the Instituto Nacional de Psiquiatía (National Institute of Psychiatry) in Mexico and were evaluated for alcohol dependence and major depressive disorder.

To learn more about the impact of depression therapy on anxiety symptoms, researchers conducted a randomized controlled clinical trial with teenagers to compare the results of personalized depression therapy to a program that does not match their risk factors.

In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.

For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.